Other relevant information
- 2025 12 02 – Reig Jofre increases its stake in LEANBIO from 47% to 85% and strengthens its vertical integration in biotechnology (PDF)
- 2025 11 05 – Reig Jofre submits press release on the results for the third quarter of 2025 (PDF)
- 2025 11 05 – Reig Jofre presents the results for the third quarter of 2025 (PDF)
- 2025 10 06 – Transactions within the liquidity contract (PDF)
- 2025 07 25 – Reig Jofre submits press release on the results of the first half of 2025 (PDF)
- 2025 07 25 – Reig Jofre presents the results for the first half of 2025 (/wp-content/uploads/2025-07-25-NOTA-RESULTADOS-1S-EN.pdfPDF)
- 2025 07 07 – Transactions within the liquidity contract (PDF)
- 2025 06 19 – Reig Jofre informs on the start of trading of the new scrip dividend shares (PDF)
- 2025 06 10 – Reig Jofre informs on the bonus-shares capital increase (PDF)
- 2025 05 14 – Reig Jofre informs on the execution of the Scrip Dividend (PDF)
- 2025 05 09 – Reig Jofre submits the conditions and report of the Scrip Dividend (PDF)
- 2025 05 09 – Reig Jofre informs on the change of Secretary of the Company’s Board of Directors (PDF)
- 2025 05 09 – Reig Jofre submits press release on the results of the first quarter of 2025 (PDF)
- 2025 05 09 – Reig Jofre presents the results for the first quarter of 2025 (PDF)
- 2025 05 08 – Reig Jofre submits press release regarding the grant received under the European IPCEI Med4Cure project (PDF)
- 2025 04 09 – Reig Jofre submits the resolutions on 2025 General Shareholders’ Meeting (PDF)
- 2025 04 03 – Transactions within the liquidity contract (PDF)
- 2025 03 07 – Reig Jofre convenes 2024 General Shareholders’ Meeting (PDF)
- 2025 02 28 – Reig Jofre presents its 2024 financial results (PDF)
- 2025 01 07 – Reig Jofre announces the appointment of the new Director of Toledo plant (PDF)
- 2025 01 07 – Transactions within the liquidity contract (PDF)
- 2024 10 31 – Reig Jofre presents the results of the third quarter of 2024 (PDF)
- 2024 10 31 – Reig Jofre submits results note of the third quarter of 2024 (PDF)
- 2024 10 03 – Transactions within the liquidity contract (PDF)
- 2024 09 10 – Reig Jofre submits press release on the opening of its subsidiary, REIG JOFRE CZECH REPUBLIC (PDF)
- 2024 07 30 – Reig Jofre presents the results of the first half of 2024 (PDF)
- 2024 07 30 – Reig Jofre submits results note of the first half of 2024 (PDF)
- 2024 07 03 – Transactions within the liquidity contract (PDF)
- 2024 07 01 – Reig Jofre informs the liquidity contract with Solventis is extended until further notice (PDF)
- 2024 06 21 – Reig Jofre informs about the start of trading of the new scrip dividend shares (PDF)
- 2024 06 12 – Reig Jofre informs on the bonus-shares capital increase (PDF)
- 2024 05 16 – Reig Jofre informs on the execution of the Scrip Dividend (PDF)
- 2024 05 10 – Reig Jofre submits the conditions and report of the Scrip Dividend (PDF)
- 2024 05 09 – Reig Jofre submits press release on the results of the first quarter of 2024 (PDF)
- 2024 05 09 – Reig Jofre presents the results for the first quarter of 2024 (PDF)
- 2024 04 10 – Reig Jofre submits the resolutions on 2024 General Shareholders’ Meeting (PDF)
- 2024 04 08 – Reig Jofre strengthens its presence in the biotechnology sector with an investment of 5.8 million euros in Leanbio (PDF)
- 2024 04 04 – Transactions within the liquidity contract (PDF)
- 2024 03 08 – Reig Jofre convenes 2024 General Shareholders’ Meeting (PDF)
- 2024 02 29 – Reig Jofre presents the results for the fourth quarter of 2023 (PDF)
- 2024 02 29 – Reig Jofre submits press release on the results of the fourth quarter of 2023 (PDF)
- 2024 02 01 – Reig Jofre informs that the liquidity contract has been extended (PDF)
- 2024 01 03 – Transactions within the liquidity contract (PDF)
- 2024 01 02 – Reig Jofre informs that the liquidity contract has been extended (PDF)
- 2023 12 20 – Reig Jofre submits press release on on the appointment of its new Chief Financial Officer (CFO) (PDF)
- 2023 11 02 – Reig Jofre submits press release on a significant milestone achieved in collaboration with its partner, Maruishi Pharmaceutical in Japan (PDF)
- 2023 10 30 – Reig Jofre presents the results for the thrid quarter of 2023 (PDF)
- 2023 10 30 – Reig Jofre submits press release on the results of the third quarter of 2023 (PDF)
- 2023 10 05 – Transactions within the liquidity contract (PDF)
- 2023 07 27 – Reig Jofre presents the results for the second quarter of 2023 (PDF)
- 2023 07 27 – Reig Jofre submits press release on the results of the second quarter of 2023 (PDF)
- 2023 07 06 – Transactions within the liquidity contract (PDF)
- 2023 07 03 – Extension the liquidity contract (PDF)
- 2023 06 30 – Reig Jofre informs on the agreement with the European Health and Digital Executive Agency (PDF)
- 2023 06 14 – Reig Jofre informs on the start date of the trading of new shares of the Scrip Dividend (PDF)
- 2023 05 31 – Ending of the process for the bonus-shares capital increase (PDF)
- 2023 05 04 – Reig Jofre informs on the execution of the Scrip Dividend (PDF)
- 2023 05 02 – Reig Jofre submits the expected schedule related to the execution of the scrip dividend (PDF)
- 2023 04 28 – Reig Jofre informs on the Scrip Dividend Conditions (PDF)
- 2023 04 14 – Transactions within the liquidity contract (PDF)
- 2023 03 30 – Reig Jofre submits the resolutions on 2023 General Shareholders’ Meeting (PDF)
- 2023 02 28 – Reig Jofre convenes 2022 General Shareholders’ Meeting (PDF)
- 2023 02 28 – Reig Jofre submits result note on the fourth quarter of 2022 (PDF)
- 2023 01 11 – Reig Jofre informs on the begining of the liquidity contract (PDF)
- 2022 11 02 – Reig Jofre submits press release on the global license agreement reached by Syna Therapeutics (PDF)
- 2022 10 31 – Transactions within the shares buyback program (PDF)
- 2022 10 28 – Reig Jofre submits results note on third quarter of 2022 (PDF)
- 2022 10 26 – Reig Jofre announces the release date of its Q3 2022 results (PDF)
- 2022 10 24 – Transactions within the shares buyback program (PDF)
- 2022 10 17 – Transactions within the shares buyback program (PDF)
- 2022 10 11 – Transactions within the shares buyback program (PDF)
- 2022 10 03 – Transactions within the shares buyback program (PDF)
- 2022 09 27 – Transactions within the shares buyback program (PDF)
- 2022 09 19 – Transactions within the shares buyback program (PDF)
- 2022 09 12 – Transactions within the shares buyback program (PDF)
- 2022 09 05 – Transactions within the shares buyback program (PDF)
- 2022 08 29 – Transactions within the shares buyback program (PDF)
- 2022 08 22 – Transactions within the shares buyback program (PDF)
- 2022 08 15 – Transactions within the shares buyback program (PDF)
- 2022 08 08 – Transactions within the shares buyback program (PDF)
- 2022 08 01 – Transactions within the shares buyback program (PDF)
- 2022 07 26 – Reig Jofre submits results note on second quarter of 2022 (PDF)
- 2022 07 25 – Transactions within the shares buyback program (PDF)
- 2022 07 25 – Reig Jofre informs on the start date of the trading of the new shares within its scrip dividend (PDF)
- 2022 07 18 – Transactions within the shares buyback program (PDF)
- 2022 07 12 – Reig Jofre informs on the start of the Temporary Share Buyback Program (PDF)
- 2022 07 12 – Reig Jofre informs on the bonus-shares capital increase and the new shares to be issued for its scrip dividend (PDF)
- 2022 07 06 – Transactions within the liquidity contract (PDF)
- 2022 06 14 – Reig Jofre informs on the execution of the Scrip Dividend (PDF)
- 2022 06 09 – Reig Jofre informs on the Scrip Dividend Conditions (PDF)
- 2022 04 28 – Reig Jofre submits the resolutions on 2022 General Shareholders’ Meeting (PDF)
- 2022 04 05 – Transactions within the liquidity contract (PDF)
- 2022 03 26 – Reig Jofre convenes 2022 General Shareholders’ Meeting (PDF)
- 2022 02 28 – Reig Jofre submits results note on fourth quarter of 2021 (PDF)
- 2022 01 18 – Reig Jofre informs on the begining of the liquidity contract (PDF)
- 2022 01 10 – Transactions within the shares buyback program (PDF)
- 2021 12 27 – Transactions within the shares buyback program (PDF)
- 2021 12 20 – Transactions within the shares buyback program (PDF)
- 2021 12 07 – Transactions within the shares buyback program (PDF)
- 2021 11 29 – Transactions within the shares buyback program (PDF)
- 2021 11 22 – Transactions within the shares buyback program (PDF)
- 2021 11 15 – Transactions within the shares buyback program (PDF)
- 2021 11 08 – Transactions within the shares buyback program (PDF)
- 2021 11 04 – Transactions within the shares buyback program (PDF)
- 2021 10 29 – Reig Jofre submits results note on third quarter 2021 (PDF)
- 2021 10 25 – Transactions within the shares buyback program (PDF)
- 2021 10 18 – Transactions within the shares buyback program (PDF)
- 2021 10 11 – Transactions within the shares buyback program (PDF)
- 2021 10 04 – Transactions within the shares buyback program (PDF)
- 2021 09 27 – Transactions within the shares buyback program (PDF)
- 2021 09 20 – Transactions within the shares buyback program (PDF)
- 2021 09 13 – Transactions within the shares buyback program (PDF)
- 2021 09 06 – Transactions within the shares buyback program (PDF)
- 2021 08 30 – Transactions within the shares buyback program (PDF)
- 2021 08 23 – Transactions within the shares buyback program (PDF)
- 2021 08 16 – Transactions within the shares buyback program (PDF)
- 2021 08 10 – Transactions within the shares buyback program (PDF)
- 2021 08 02 – Transactions within the shares buyback program (PDF)
- 2021 07 29 – Reig Jofre submits results note on second quarter 2021 (PDF)
- 2021 07 26 – Transactions within the shares buyback program (PDF)
- 2021 07 22 – Acquisition of 100% of the subsidiary REIG JOFRE UK LT (PDF)
- 2021 07 21 – Start of the trading of the new shares within its scrip dividend (PDF)
- 2021 07 19 – Transactions within the shares buyback program (PDF)
- 2021 07 06 – Start of the second temporary share buyback program (PDF)
- 2021 07 06 – Increase in the bonus-share capital and new shares to be issued (PDF)
- 2021 07 05 – Termination of the liquidity contract (PDF)
- 2021 06 09 – Execution of the scrip dividend (PDF)
- 2021 06 04 – Conditions of the scrip dividend (PDF)
- 2021 05 11 – Changes in the Board of Directors (PDF)
- 2021 04 29 – Resolutions on 2021 General Shareholders’ Meeting (PDF)
- 2021 04 26 – Reschedule of Q1 2021 results (PDF)
- 2021 04 20 – Reig Jofre announces the opening of a subsidiary in Poland (PDF)
- 2021 04 07 – Transactions within the liquidity contract in Q1 2021 (PDF)
- 2021 03 26 – Reig Jofre convenes General Shareholders Meeting of 2021 (PDF)
- 2021 02 26 – Reig Jofre presents the fourth quarter 2020 results (PDF)
- 2021 02 19 – Publication schedule for 2021 quarterly results (PDF)
- 2021 01 21 – Start of the liquidity contract (PDF)
- 2021 01 11 – Transactions within the shares buyback program (PDF)
- 2021 01 04 – Transactions within the shares buyback program (PDF)
- 2020 12 28 – Transactions within the shares buyback program (PDF)
- 2020 12 21 – Transactions within the shares buyback program (PDF)
- 2020 12 14 – Transactions within the shares buyback program (PDF)
- 2020 12 07 – Transactions within the shares buyback program (PDF)
- 2020 11 30 – Transactions within the shares buyback program (PDF)
- 2020 11 23 – Transactions within the shares buyback program (PDF)
- 2020 11 16 – Transactions within the shares buyback program (PDF)
- 2020 11 09 – Transactions within the shares buyback program (PDF)
- 2020 11 02 – Transactions within the shares buyback program (PDF)
- 2020 10 23 -Reig Jofre informs on the start date of the trading of the new shares within its scrip dividend (PDF)
- 2020 10 19 – Transactions within the shares buyback program (PDF)
- 2020 10 13 – Transactions within the shares buyback program (PDF)
- 2020 10 09 – Reig Jofre informs on the bonus-shares capital increase and the new shares to be issued (PDF)
- 2020 10 05 – Transactions within the shares buyback program (PDF)
- 2020 09 28 – Transactions within the shares buyback program (PDF)
- 2020 09 21 – Transactions within the shares buyback program (PDF)
- 2020 09 15 – Reig Jofre informs on the execution of the scrip dividend (PDF)
- 2020 09 11 – Reig Jofre informs on the conditions of the scrip dividend (PDF)
- 2020 09 07 – Transactions within the shares buyback program (PDF)
- 2020 08 31 – Transactions within the shares buyback program (PDF)
- 2020 08 17 – Transactions within the shares buyback program (PDF)
- 2020 08 10 – Transactions within the shares buyback program (PDF)
- 2020 08 05 – Transactions within the shares buyback program (PDF)
- 2020 07 27 – Transactions within the shares buyback program (PDF)
- 2020 07 23 – Reig Jofre presents the second quarter 2020 results (PDF)
- 2020 07 23 – Reig Jofre releases first half 2020 results note (PDF)
- 2020 07 23 – Resolutions of the General Shareholders’ Meeting (PDF)
- 2020 07 21 – Transactions within the shares buyback program (PDF)
- 2020 07 13 – Transactions within the shares buyback program (PDF)
- 2020 07 07 – Transactions within the shares buyback program (PDF)
- 2020 07 06 – Termination of the liquidity contract (PDF)
- 2020 07 02 – Start of the first temporary share buyback program (PDF)
- 2020 07 01 – Termination of the liquidity contract (PDF)
- 2020 06 18 – Reschedule of 1H 2020 results (PDF)
- 2020 06 17 – Reig Jofre convenes the Ordinary General Shareholders’ Meeting (PDF)
- 2020 05 06 – Beginning of a clinical study to reduce the incidence of COVID-19 (PDF)
- 2020 04 03 – Transactions in relation to the Liquidity Contract (PDF)
- 2020 03 23 – General Shareholders’ Meeting postponed (PDF)